NNE Pharmaplan is the leading engineering and consulting company for the pharmaceutical industry. That is a position we have earned. The industry knows that we care as much as they do about the end result of our joint efforts. We are dedicated to serving the worldwide pharma and biotech industries with engineering and consulting services. Our growth has stemmed from the pharmaceutical history of Novo Nordisk and Fresenius, and we are keeping our business focus fixed on serving the pharmaceutical companies all over the world – large, midsized and small - in their local or global needs.
The pharmaceutical industry is only 100 years old, but it has had a remarkable history. It has created major breakthroughs that have changed the lives of people everywhere in several very important areas, such as: penicillin’s fight against infectious diseases, insulin’s successful treatment of diabetes, monoclonal antibodies’ fight against cancer – and more advancements and discoveries will surely follow.
During the last century the industry has only grown, and, although it is ranked the most profitable on the Fortune 500, the profits are not earned by sitting back and counting patent income. The profits reflect a business founded on, and driven by, new ideas. The key words are Research & Development. On average, out of every 10,000 substances synthesised in laboratories, only one or two will pass all the experimental stages to become marketable medicines. In 2009, the cost of researching and developing a new chemical or biological entity was estimated at 1,000 million Euros. By the time a medical product is introduced on the market, an average of 12-13 years will have elapsed since the synthesis of the new substance.
Needless to say, the rapid development of the industry that we serve with engineering and consulting calls for the equally rapid development of our company: a development that we hope you will want to be part of.